MSD announce David Peacock as new Managing Director in UK and Ireland

pharmafile | October 1, 2019 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

MSD have announced that David Peacock will become Managing Director in the UK and Ireland, succeeding former director Louise Houson, with a start date of October 1st 2019.

Peacock brings with him a broad range of experience and perspectives from senior roles within the company in the United States, Singapore, Vietnam and Japan. Most recently, David was Chief of Staff to Kenneth Frazier, Chairman of the board and Chief Executive Officer of MSD.

He has also held other significant roles within the company as Managing Director of Hong Kong and Macau and the Chief Financial Officer for MSD in Japan.

David said: “I am delighted to have been appointed managing director of MSD in the UK and Ireland.

“MSD has both a rich heritage and continued focus on scientific invention of medicines and vaccines to improve the health and wellbeing of populations and patients. I am honoured to have this leadership role and humbled to continue MSD’s legacy here.

“We know we can’t solve today and tomorrow’s healthcare challenges alone, and I am looking forward to working with our team to build on our existing relationships with partners so that our innovations reach as many eligible patients as possible in the UK.”

Louis Houson, who has held the position of managing director for MSD in the UK and Ireland for over three years will now be taking on a leadership role in MSD’s global vaccines organisation in the United States.

Related Content

No items found

Latest content